Neowiz says the team behind "Pinocchio's Lies" is developing a new IP horror game

Neowiz, a South Korean game publisher that successfully entered the global scene with "Pinocchio's Lies", recently revealed an eye-catching future game lineup in its investor presentation for the third quarter of 2025.The company is currently developing seven PC and console games simultaneously, including the sequel to "Pinocchio's Lies" and a number of unannounced role-playing games led by senior developers.

Neowiz称《匹诺曹的谎言》团队正开发新IP恐怖游戏

According to public information, Neowiz’s “global expansion” plan includes a rich product matrix:

Core sequel: The highly anticipated sequel to "Pinocchio's Lie" (tentative title).

New genres to try: a new life simulation game and a survival action-adventure game.

Blockbuster RPG projects: Two particularly eye-catching role-playing games - one is a new "souls-like" RPG led by creative director Kay Lee of the free-to-play MMORPG "Rocky Heroes"; the other is a narrative-oriented RPG directed by Seungho Jin, director of the suspense adventure game "Buried Stars".

In addition, the product line also includes an immersive simulation game created by Wolfeye Studios, the developer of "Wild West", and a "Black West CRPG" developed by Zakazane Studio in Warsaw.

Neowiz称《匹诺曹的谎言》团队正开发新IP恐怖游戏

According to previous news, Round8 Studio, the development team of "Pinocchio's Lie", is also using Unreal Engine 5 to create a new science fiction survival horror game.Although Neowiz officially stated that "it is too early to disclose project progress or details," it has been confirmed that this will be Round8 Studio's new IP after "Pinocchio's Lies", aiming to follow the footsteps of classic works such as "Dead Space" and enter the survival horror game market with a fixed audience.

Neowiz称《匹诺曹的谎言》团队正开发新IP恐怖游戏

This series of actions clearly shows that Neowiz, after becoming famous with a single hit, is actively expanding its global influence and product reserves through a multi-project and multi-type parallel strategy.